Inventiva cuts pipeline, halves staff in bid to get to Phase 3 MASH readout
Inventiva is trimming its pipeline and enacting layoffs in an effort to get its lead MASH drug approved, the company announced Monday afternoon. The plan will center around its MASH candidate called lanifibranor, a pan ...
Inventiva is trimming its pipeline and enacting layoffs in an effort to get its lead MASH drug approved, the company announced Monday afternoon.
The plan will center around its MASH candidate called lanifibranor, a pan ...
